
Bristol-Myers Squibb will not attempt to bring its new combination hepatitis C treatment to the US market given the current …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

